This app disappeared from Google Play on 2026-11-15. Below is the last data we saved.
100+
installs · ≈173
—
0 ratings
2022-04-26
first release
2026-05-14
last update
Description
Solely intended for participants in the Daiichi Sankyo HERTHENA Lung02 study
This app has been exclusively created for participants in the medical study for Daiichi Sankyo HERTHENA–Lung02. It contains Televisit functionality and allows participants to complete questionnaires.
The Daiichi Sankyo HERTHENA–Lung02 study is a Phase 3, randomized, open-label study of Patritumab Deruxtecan versus platinum-based chemotherapy in metastatic or locally advanced Epidermal Growth Factor Receptor-mutated (EGFRm) Non-small Cell Lung Cancer (NSCLC) after failure of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) therapy
Details
| Version | 5.0.1300.01-prod |
|---|---|
| Minimum Android version | 6.0 |
| Reviews | 0 |
| Available in | American Samoa, Austria, Australia, Belgium, Bulgaria, Canada, Switzerland, Germany, Spain, United Kingdom, Guam, Hong Kong SAR China and 15 more |
| Developer contacts | on the Business plan |
| Collected | 2026-11-14 |
This data in the API
The full record in JSON costs 1 token.
curl -H "X-API-Key: YOUR_KEY" \ "https://apkapi.com/api/v1/app?id=com.medable.syneos.u31402au301"
